Public Policy

Scientists are in the unique position to directly convey the benefits of human genetics and genomics research to policymakers. It is critical that we communicate the benefits of human genetics and genomics research to Congress because decisions happen on the Hill that affect research and the use of genetics-based technologies – with or without our... Read More

Published: Wednesday, May 11, 2022, 4:00 PM U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org ROCKVILLE, MD – Today, the American Society of Human Genetics (ASHG) hosted its 2022 Capitol Hill Day bringing together 21 researchers, clinicians and other advocates from across the country to meet with key members of Congress and their staff to discuss shared... Read More

Dr. Muin Khoury is the Director at the Office of Genomics and Precision Public Health at the CDC. The Office of Genomics and Precision Public Health was formed in 1997 to assess the impact and advantages of human genetics and the Human Genome Project on public health and disease prevention. Over the decades, the office... Read More

Last month, ASHG launched the new Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program. ACGT is a competitive, year-long program aimed at providing trainee ASHG members pursuing a research or clinical career with an introduction to science policy and human genetics and genomics advocacy. The program is a Government and Public Advocacy Committee... Read More

Applications for the 2024 cohort are closed. ASHG is committed to helping our members champion human genetics and genomics research, and advocate for policies that support research and advance the field. The Society provides opportunities and resources to support members in engaging with policymakers through the ASHG Advocates network and the Advocacy Center. Building on these successes, ASHG... Read More